Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BAY2862789 |
Synonyms | |
Therapy Description |
BAY2862789 is a DGK-alpha inhibitor, which may increase TCR signaling and enhance antitumor immune response (Journal for ImmunoTherapy of Cancer 2024;12, NCI Drug Dictionary). |